Patent · US Expired

Method of intracellular binding target molecules

US6329173A · kind A · utility

51Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 21, 2000
Grant dateDec 11, 2001
Priority date
Expiry dateApr 21, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method by which one can target an undesired target molecule or target antigen, preferably a protein. The method comprises the intracellular expression of an antibody capable of binding to the target. A DNA sequence is delivered to a cell, the DNA sequence contains a sufficient number of nucleotides coding for the portion of an antibody capable of binding to the target operably linked to a promoter that will permit expression of the antibody in the cell(s) of interest. The antibody is then expressed intracellularly and binds to the target, thereby disrupting the target from its normal actions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.